OmniaBio
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
190 Longwood Rd S, Hamilton, Ontario, L8...Phone Number
(226) 640-0759Website
www.omniabio.comRevenue
$63.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
1
About OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.Explore more
OmniaBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OmniaBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if OmniaBio had a recent Job posting/layoffs
Earning: See what the market has to say on OmniaBio recently announced quarterly report
OmniaBio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if OmniaBio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at OmniaBio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once OmniaBio has new funding data
Check if OmniaBio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when OmniaBio launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to OmniaBio
Compare insights from companies similar to OmniaBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OmniaBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OmniaBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OmniaBio.
OmniaBio Tech Stack
A closer look at the technologies used by OmniaBio
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
OmniaBio has more open roles in Legal than it has had at any time in the past 12 months. Areas of expertise include: Internal Auditing, Client Account Auditing, Change Control, and Quality Management Systems.
Hiring Plans
Open Position
Open Position
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
OmniaBio News & Media
OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients
The site will add state-of-the-art CGT capacity and employ artificial intelligence and automation to achieve critical product supply efficiencies for North American and global biotherapy clients HAMILTON, ON, Oct. 18, 2024 /PRNewswire/ -- Today OmniaBio Inc. will announce the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) centre of excellence, which is now Canada's largest contract development and manufacturing organization (CDMO) facilSomite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite's Cell Therapy Flagship Program
CDMO collaboration propels cell replacement therapy targeting Duchenne muscular dystrophy forward, with consequences for the role of AI in cell therapy BOSTON and HAMILTON, Ontario, Sept. 9, 2024 /PRNewswire/ -- Somite Therapeutics, a tech-bio company harnessing big data and AI to pioneer...CATTI opens a cell and gene therapy training centre of excellence at the University of Guelph
GUELPH, ON, May 15, 2023 /PRNewswire/ - The Canadian Advanced Therapies Training Institute (CATTI) Inc. has launched its first in-person training site at the University of Guelph through a partnership with OmniaBio Inc., CCRM and the university. The training program, to begin in summer...Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies
BOSTON & TORONTO--(BUSINESS WIRE)--Catamaran Bio Inc., a biotechnology company developing off-the-shelf NK cell therapies to treat cancer, and OmniaBio Inc., a contract development and manufacturing organization (CDMO) focused on cell and gene therapy, today announced their partnership to develop and manufacture Catamaran Bio’s allogeneic chimeric antigen receptor (CAR)-NK cell therapies for the treatment of solid tumors. “This collaboration will allow us to develop scalable processes for the r
Read more news
Top Chemicals & Related Products Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding OmniaBio
Sign Up For FreeTo access detailed company insights
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in... Read More
